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ABSTRACT The various symptomatic outcomes of cutaneous leishmaniasis
relates to the type and potency of its underlying inflammatory responses.
Presence of the cytoplasmic Leishmania RNA virus-1 (LRV1) within Leishmania
guyanensis, worsens lesional inflammation and parasite burden, as the viral
dsRNA genome acts as a potent innate immunogen stimulating Toll-LikeReceptor-3 (TLR3). Here we investigated other innate pattern recognition receptors capable of reacting to dsRNA and potentially contributing to LRV1mediated inflammatory pathology. We included the cytoplasmic dsRNA sensors, namely, the RIG-like receptors (RLRs) and the inflammasome-dependent
and -independent Nod-like-receptors (NLRs). Our study found no role for RLRs
or inflammasome-dependent NLRs in the pathology of L. guyanensis infection
irrespective of its LRV1-status. Further, neither LRV1-bearing L. guyanensis
(LgyLRV1+) nor LRV1-negative L. guyanensis (LgyLRV1-) activated the inflammasome in vitro. Interestingly, similarly to L. donovani, L. guyanensis infection induced the up-regulation of the A20 protein, known to be involved in
the evasion of inflammasome activation. Moreover, we observed that
LgyLRV1+ promoted the transcription of inflammasome-independent NLRC2
(also called NOD2) and NLRC5. However, only NLRC2 showed some contribution to LRV1-dependent pathology. These data confirmed that the endosomal
TLR3 pathway is the dominant route of LRV1-dependent signalling, thus excluding the cytosolic and inflammasome pathways. We postulate that avoidance of the inflammasome pathways is likely an important mechanism of
virulence in Leishmania infection irrespective of the LRV1-status.

INTRODUCTION
The human protozoan parasite Leishmania is highly immuno-stimulatory, presenting to the host cell a variety of potent pathogen-associated molecular patterns (PAMPs) that
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Abbreviations:
ASC – apoptosis-associated speck-like
protein containing CARD,
BMDM – bone marrow derived
macrophage,
CARD – caspase activation and
recruitment domain,
CL – cutaneous leishmaniasis,
DAMP – danger-associated
molecular pattern,
DC – dendritic cell,
IFN – interferon,
IL – interleukin,
Lgy – Leishmania guyanensis,
LPS – lipopolysaccharide,
LRV – Leishmania RNA virus,
MAVS – mitochondrial antiviral
signaling protein,
NLR – Nod-like receptor,
PAMP – pathogen-associated
molecular pattern,
PRR – pattern recognition receptor,
RLR – RIG-like receptor,
TLR – Toll-like receptor.

shape the outcome of the inflammatory skin disease
known as cutaneous leishmaniasis (CL) [1]. CL is a prevalent
but neglected tropical disease affecting over 2 million people per year with an expanding geographical reach and a
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diverse clinical presentation. The various symptomatic outcomes of CL can be categorised by the type and potency of
its underlying inflammatory response: ranging from a single, self-healing lesion at the site of inoculation to chronic
hyper-inflammatory tissue destruction and the establishment of disfiguring metastatic lesions that are refractory to
routine therapies [2]. These inflammatory responses have
a high-degree of species-specificity, where metastatic and
chronic complications occur mainly in infections of the
Leishmania Viannia subgenus found in Central and South
America [3] [4].
We previously identified a cytoplasmic dsRNA virus
within metastatic L. guyanensis (Lgy) parasites that acts as
a potent innate immunogen capable of worsening lesional
inflammation [5] and prolonging infected macrophage survival [6]. The dsRNA genome of Leishmania RNA virus
(LRV1) binds to and stimulates endosomal Toll-LikeReceptor-3
(TLR3),
inducing
destructive
hyperinflammation [5] and metastasis in an immunosuppressed
environment [7]. Further, the presence of LRV1 in L. guyanensis and L. braziliensis negatively affects the patients
response to anti-Leishmania drugs, as it is predictive of
treatment failure and symptomatic relapses [8, 9], and
potentially worsens the disease outcome in patients coinfected with HIV [10].
By recognising PAMPs and danger-associated molecular
patterns (DAMPs) via innate pattern recognition receptors
(PRRs), the mammalian immune system can respond rapidly to infection and tissue damage. These PRRs are able to
initiate a wide variety of robust inflammatory pathways
tailored to suit the stimulatory ligand. Depending on their
ligand specificity, localization and signalling pathway, PRRs
are classified into three major families: the TLRs (Toll-like
receptors), the RLRs (retinoic acid-inducible gene-I-like
receptors) [11] and the NLRs (nucleotide-binding-domain,
leucine-rich repeat containing receptors).
RLRs are a small family of RNA helicase enzymes found
exclusively in the cytosol that launch an anti-viral response
after binding cytosolic RNA [12]. Most active in dendritic
cells (DCs), macrophages and fibroblasts, RLRs comprise of
two major family members: RIG-I (retinoic acid-inducible
gene-I) and MDA-5 (melanoma differentiation-associated
protein 5) that are activated by binding cytosolic RNA. RIG-I
typically recognizes 5’ triphosphate short uncapped dsRNA
and ssRNA, while MDA-5 recognises longer dsRNA strands
[13]. Both RIG-I and MDA-5 signal through a common
adaptor molecule, MAVS (mitochondrial antiviral signalling
protein) to induce a type I interferon (IFN) mediated antiviral response via IRF-3 as well as an NF-B-type inflammatory response [14]. As RLRs are present in the cytosol, their
involvement in LRV1-mediated leishmaniasis would indicate that LRV1 is able to exit the phagolysosome, where
the parasite survives, and to reach the host cell cytoplasm.
DAMPs such as intracellular content released from dying cells (e.g. nucleic acids, heat-shock proteins and ATP) or
damaged components of the extracellular matrix (e.g. hyaluronic acid) are recognised by NLRs. NLR sensing of
DAMPs can result in a potent immune response or an in-
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flammatory form of cell death, termed pyroptosis. Additionally, several NLRs are able to respond to PAMPs such as
bacterial cell wall components and viral RNA. NLR activation can be accomplished in a fashion similar to that of
TLRs, where NF-B or IRFs are mobilised to produce proinflammatory cytokines or type I IFNs, respectively. Alternatively, several NLRs can oligomerise to form a large macromolecular scaffold, called the “inflammasome”. Currently, 7 of the 22 human NLR members are known to oligomerise into inflammasomes, namely, NRLB/NLRC4 [15] and
NLRP-1, -3, -6, -7, and -12 [16-20]. The inflammasome recruits and activates inflammatory caspases leading to the
cleavage and activation of pro-IL-1β and pro-IL-18 [21, 22].
They are formed by the oligomerization of caspase activation and recruitment domains (CARDs), which are either
included in the NLR structure such as NLRC4 and NLRP1 or
recruited in an ASC (apoptosis-associated speck-like protein containing CARD) protein, which is the case for the
formation of the NLRP3, 6, 7, and 12 inflammasome. Additionally, the non-NLR protein, absent in melanoma 2
(AIM2), which contains pyrin and HIN200 domains, senses
dsDNA to form an inflammasome by ASC recruitment [23].
To date, only a few studies have thoroughly explored
the role of inflammasomes in leishmaniasis. The clearance
of L. amazonensis, L. infantum and L. braziliensis species is
correlated to an NLRP3-dependent production of nitric
oxide and IFN-γ [24]. The authors show that the NLRP3
inflammasome activates IL-1β, and that the IL-1 receptor
and its MyD88 adaptor protein are necessary and sufficient
to trigger parasitotoxic oxidative stress. Different components of the NLRP3 inflammasome were found to be upregulated also in a macrophage system of L. major infection [25]. However, oppositely to the observation in L. infantum and L. braziliensis, inflammasome activation worsens the outcome of L. major infection, accelerating the
course of disease or inducing non-healing lesions [26, 27].
Predictably, the effects of inflammasome activity could
differ widely amongst various Leishmania species, ranging
from protective in L. amazonensis, L. infantum and L.
braziliensis infection [24] to pathogenic in cutaneous species from the Paleotropics [26, 27] and contrasting in visceralizing L. donovani, where it has been involved in the
development of protective immunity [28] but has also recently been correlated with increased visceralization if
activated by gut bacteria transmitted during a sand fly bite
[29]. Of note, however, IL-1α, IL-1β and IL-18 can be activated independently of the inflammasome [30] and thus
these roles are not necessarily indicative of NLR activity.
Recently, A20 (also named TNF-α-induced protein 3), a
deubiquitinating protein, was reported to inhibit NF-κB
activation by deubiquitinating TRAF6 and also to block inflammasome activation by inhibiting IL-1β maturation independently of its effect on NF-kB [31]. In L. donovani infection, A20 was shown to inhibit TLR signalling, decreasing
the pro-inflammatory response, thus favouring parasite
survival [32] by blocking both pro-IL-1β and pro-caspase-1
maturation [33].
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In this study, we investigated the role of several nonTLR3 pathways of viral dsRNA recognition during LRV1mediated pathology in a murine model of Lgy infection. To
this end, we performed an expression array of NLR and RLR
components in Lgy infection, probing for markers of Lgy
induced inflammasome activation at a cellular level. We
then tested the role of these components on LRV1dependent leishmanial pathology in a murine model of
infection.

RESULTS
LRV1 does not activate RLR signaling
MAVS is the common adaptor molecule essential in the
signalling of RIG-I and MDA-5 [34]. Therefore, to investigate whether RLRs contributed to LRV1-mediated parasite

survival and inflammation, we infected bone marrow derived macrophages (BMDMs) from C57BL/6 (WT) and
MAVS-/- mice with LgyLRV1+ or LgyLRV1- parasites. We
found that the absence of MAVS did not affect LRV1induced up-regulation of the signature NF-B cytokines IL6 and TNF-α (Fig 1A and 1B). Subsequently, to include the
effect of all cells in which RLRs may be activated in the
context of the leishmanial lesion, we monitored disease
progression in a murine model of infection. Here, mice
lacking MAVS signalling did not show any visible variation
in lesional swelling (Fig 1C) or parasite burden (Fig 1D), as
compared to the WT control. Thus, we could exclude RLRs
as sensor molecules participating in an LRV1-dependent
exacerbation of the disease and conclude that LRV1 dsRNA
does not reach the host cell cytoplasm.

FIGURE 1: LRV1 does not activate RLR signaling. (A, B) BMDMs from mice deficient in MAVS and their C57BL/6 WT counterparts were infected with LgyLRV1+ or LgyLRV1- parasites or stimulated with a synthetic TLR3 ligand, poly(I:C). After 24 hours, the NF-B cytokines, IL-6
(A) and TNF-α (B) in BMDM supernatant were quantified by ELISA. (C, D) MAVS-/- and C57BL/6 WT mice were infected with LgyLRV1+ or
LgyLRV1- parasites in their hind footpads. (C) Weekly lesional swelling was monitored as a proxy for disease progression. (D) At the peak of
infection (4 weeks), parasite burden was measured by in vivo luminescence, by injecting mice intra-peritoneally with 15 mg/kg luciferin.
Data is representative of a minimum of three independent experiments, using at least five mice per condition, and showed as mean ± SEM.
Significance tested by Student’s t-test (bar graphs) or one-way Anova (disease score), ns: non-significant.
OPEN ACCESS | www.microbialcell.com
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LRV1 promotes the transcription of the inflammasome
components, caspase-1, IL-1β, NLRP3 and AIM2
To identify the possible interaction between LRV1 and the
inflammasome, we performed an expression assay of the
key inflammasome signalling transducers as well as the
major inflammasome-forming PRR family. We focused on
genes encoding the common inflammasome components
asc, caspase 1 and il1beta (Fig 2A), and the inflammasomeforming members nlrc4 and naip5 (Fig 2B), the NLRP family
members nlrp1, nlrp3, nlrp12 (Fig 2C) and a non-NLR inflammasome-forming molecule aim2 (Fig 2D). BMDMs
were infected with LgyLRV1+ or LgyLRV1- parasites, or
stimulated with the synthetic TLR3 agonist, poly(I:C), and
then prepared for qRT-PCR analysis. We found that TLR3
stimulation was able to potently induce the transcription of
genes including caspase-1, IL-1β, nlrp3 and aim2 but not
asc, nlrc4, naip5, nlrp1 and nlrp12 (Fig 2). Taken together,
these results showed that LRV1 and poly(I:C) mediated
TLR3 activation can prime the inflammasome components
and promote the transcription of certain NLRs and AIM2.

L. guyanensis does not activate the inflammasome in
macrophages, irrespective of its LRV1 status
Based on the transcriptional data, we could expect that
LRV1 would activate the inflammasome. Such activation
involves the autocatalytic cleavage of pro-caspase 1 into its
p20 and p10 subunits. In turn, active caspase-1 cleaves and
activates pro-IL-1β and pro-IL-18. Importantly, while pro-IL18 and pro-caspase-1 are constitutively expressed, the
transcription of pro-IL-1β is under the control of NF-κB.
Therefore, inflammasome activity requires a “priming”
step via NF-κB activation before a second signal activates
the inflammasome. NF-κB-dependent TLR3 signalling as
observed in dsRNA activation is one such pathway leading
to inflammasome priming [22, 35].
To investigate whether we were able to activate the inflammasome in our BMDMs, we primed BMDMs with lipopolysaccharide (LPS) for 3 hours before LgyLRV1+ or
LgyLRV1- infection, and added nigericin treatment as a
positive control of inflammasome activation. Cell lysates
and cell culture supernatants were probed for the pro- and
cleaved forms of caspase-1 by immunoblotting (Fig 3A).
LgyLRV1+ infection or poly(I:C) treatment increased the
expression of the pro-form of IL-1β, and thus acted as pri-

FIGURE 2: LRV1 promotes the transcription of the inflammasome components, caspase-1, IL-1β, NLRP3 and AIM2. BMDMs from C57BL/6
mice were infected with LgyLRV1+ or LgyLRV1- parasites or stimulated with a synthetic TLR3 ligand, poly(I:C). After 6 hours and 12 hours,
mRNA was quantified by qRT-PCR. (A) The common inflammasome components ASC, Caspase-1 and IL-1β and the inflammasome-forming
members of the (B) NLRC family, (C) NLRP family and (D) a non-NLR inflammasome-forming molecule, AIM2 were measured. Levels are
representative of both 6-hour and 12-hour time points. Representative results are shown from at least three independent experiments,
using two technical and two biological replicates, and showed as mean ± SEM. Non-parametric Student’s t-test is shown. *p < 0.05, **p <
0.01, ***p < 0.001. A cut off value of 2-fold was used as a limit of significance and is indicated as a dotted line.
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ming signals. However, L. guyanensis parasites, irrespective
of their LRV1 status did not activate the inflammasome in
BMDMs, since the IL-1β cytokine and cleaved active caspase-1 could not be detected in the cell supernatant (Fig 3A
and 3B). Taken together, we were able to definitively exclude inflammasome activation in the macrophage host
cell during infection with L. guyanensis parasites.
The inflammasome does not contribute to disease pathology in a murine model of Lgy infection, irrespective of
its LRV1 status
As the macrophage is just one of the many cells with potential inflammasome activity in the skin [36, 37], it was
important to verify inflammasome activity in the physiological context of an in vivo infection. Using mice deficient in
caspase1/11 (thus lacking both the canonical caspase-1dependent and non-canonical caspase-11-dependent
pathway of inflammasome activation [38]) or ASC, we
found no significant differences in the development of
lesional swellings for Lgy infection, irrespective of LRV1
presence (Fig 4A and 4B). These mice also did not display
any differences in parasite burden at the peak of infection
as quantified by in vivo luminescence (Fig 4C and 4D).
Moreover, the conditional knockouts of a floxed asc gene
using CRE expression in DCs, macrophages or keratinocytes
mediated by promoters Itgax (CD11c), lysosome 2 (LysM)
and keratin 14 (K14), respectively, did not affect the LRVmediated disease progression in mice, thus allowing us to
exclude the contribution of the inflammasome of other cell
types such as DCs, neutrophils and keratinocytes that are
present in lesions (Fig S1). Consistent with these results,
the parasite burden in macrophages deficient in ASC,
caspase-1 and IL-1β were similar to WT macrophages 24

hours post infection (Fig 4E). In conclusion, the inflammasome did not have any effect on lesional pathology or
parasite burden in Lgy infection irrespective of its LRV1
status.
L. guyanensis induces the expression of the inflammasome-inhibitor protein A20
Recently, A20 was further shown to promote L. donovani
virulence, as it inhibits inflammasome formation possibly
by blocking pro-IL-1β and procaspase-1 maturation [33].
Considering that we observed an inhibition of the activation of the inflammasome, we investigated whether
LgyLRV1+ or LgyLRV1- could induce the expression of A20.
We therefore infected BMDMs with LgyLRV1+ or LgyLRV1and analysed cell lysates for increased expression of A20 by
immunoblot at 4 and 8 hours post infection. As a positive
control, we infected BMDMs with two strains of L. infantum and analysed A20 expression. Similarly to L. infantum,
in our model of macrophage infection, LgyLRV1+ and
LgyLRV1- induced the expression of A20 (Fig 5A), suggesting its possible involvement in the inhibition of inflammasome activation by blocking IL-1β maturation [31]. To
better assess LRV1 involvement in A20 induction, we quantified by densitometric analysis the expression of A20 in
LgyLRV1+ or LgyLRV1- infected or poly(I:C) treated macrophages. Interestingly, at early time points, infection with
LgyLRV1+ parasites significantly increased A20 expression
compared to both LgyLRV1- infection or poly(I:C) treatment, suggesting an additive effect between Leishmania
infection and TLR3 stimulation (Fig 5B).

FIGURE 3: L. guyanensis does not activate the inflammasome in macrophages, irrespective of its LRV1 status. (A-B) BMDMs from C57BL/6
WT mice were primed with 200 ng/ml of LPS for 3 hours. Subsequently, cells were incubated with LgyLRV1+ or LgyLRV1- parasites, poly(I:C)
or culture medium. Additionally, a 1 hour treatment with 5 µM of Nigericin was used as a positive control for the inflammasome activation.
Proteins were extracted from cell lysates (CL) and supernatants (SN). (A) Cell lysates were blotted for caspase-1. (B) IL-1β detected by ELISA
in cell-free supernatant. Graphs are representative of a minimum of three independent experiments, using four technical and two biological
replicates, and showed as mean ± SEM. Non-parametric Student’s t-test was used to calculate significance.
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FIGUER 4: The inflammasome does not contribute to disease pathology in a murine model of Lgy infection, irrespective of its LRV1 status. WT, ASC-/- and Caspase1/11-/- mice were infected with LgyLRV1+ or LgyLRV1- parasites in their hind footpads. (A, B) Weekly lesional
swelling was monitored as a proxy for disease progression. (C, D) At the peak of infection (4 weeks), parasite burden was measured by in
vivo luminescence, by injecting mice intra-peritoneally with 15mg/kg luciferin. (E) BMDMs derived from C57BL/6 mice deficient in ASC,
Caspase-1/11 and IL-1β were infected with either LgyLRV1+ or LgyLRV1- parasites for 24 hours then stained with DAPI and acquired using
high-content microscopy. Parasite burden was unbiasedly quantified using computational image analysis. The data shown is representative
of a minimum of three independent experiments, using at least 5 mice per condition, and showed as mean ± SEM. Statistical significance
was quantified by performing Student’s t-test (bar graphs) or one-way Anova (disease score), ns: non-significant.

LRV1 induces the expression of inflammasomeindependent NLRs: NLRC1, NLRC2 and NLRC5
Many of the inflammasome-independent NLR family members are able to recognise viral components and often use
signalling pathways similar to that of the TLR3-LRV1 response. To identify NLRs of interest in our model, we
screened BMDMs for LRV1-induced expression of the inflammasome-independent NLR members that are known
components of the anti-viral response.
NLRC2 can act as a cytoplasmic PRR for ssRNA, the replicative RNA and mRNA of Totiviridae [39], and signal
through MAVS to promote IFN-β transcription via IRF3 [40].
However, in macrophages stimulated with poly(I:C) NLRC2
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is not implicated in the production of IFN-β, TNF-α and IL-6
[40]. Oppositely, it was reported that NLRC1 and NLRC2 are
induced in response to viral infection, poly(I:C) or IFN-β
stimulation and to enhance the production of proinflammatory cytokines [41]. Further, NLRC2 promotes the
CCL2-dependent recruitment of inflammatory monocytes
[42]. To test for the expression of NLRC1 and NLRC2 in our
in vitro infection model, we infected WT BMDMs with
LgyLRV1+ or LgyLRV1- parasites, or stimulate them with
poly(I:C). Six hours post infection, BMDMs were lysed and
the expression of different NLR transcript was measured by
qRT-PCR. In accordance with published data, we observed
that both LRV1 and poly(I:C) stimulation promoted the
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FIGURE 5: L. guyanensis and L. infantum infection induce the up-regulation of the inflammasome inhibitory factor, A20. BMDMs from
C57BL/6 WT mice were infected with LgyLRV1+, LgyLRV1-, Linf S1 or Linf S2 parasites or stimulated with poly(I:C) (p(I:C)) as a positive control
for TLR3 activation. (A) At 4 or 8 hours after infection, cells were collected, proteins were extracted from cell lysates and were blotted for
A20 and γ-tubulin. (B) Quantification of protein expression of LgyLRV1+ or LgyLRV1- infected or poly(I:C) treated macrophages. The graph is
representative of four independent experiments, and shown as mean ± SD. Two-way ANOVA was used to calculate significance. *p < 0.05;
**p < 0.01; ns: non-significant.

transcription of nlrc1 and nlrc2 (Fig 6A). Further, it was
reported that NLRX1 [43], NLRC3 [44] and NLRC5 [45, 46]
negatively regulate mitochondrial antiviral immune signalling. Here, we observed that the stimulation of macrophages with poly(I:C) or LgyLRV1+ resulted in the induction
of nlrc5 (Fig 6B), whereas the expression of nlrx1 and nlrc3
was unaltered (Fig 6B). Together, these results indicated
that LRV1-mediated TLR3 activation can act as a priming
signal for certain inflammasome-independent NLRs.
NLRC2 deficiency in mice reduces LRV-mediated
pathogenesis
To determine whether LRV1-mediated upregulation of
NLRC2 or NLRC5 in macrophages plays a pathogenic role in
LgyLRV1+ infected mice, we investigated disease progression among mice deficient in NLRC2 or NLRC5 as compared
to WT mice. Mice lacking NLRC2, showed significantly reduced parasite load and lesion swelling (Fig 7A and 7B).
Oppositely, no discernible difference was seen between
WT and NLRC5-/- mice (Fig 7C and 7D). These results indicate that LRV1 promotes the virulence of its microbial host
partially through NLRC2 in mice.
DISCUSSION
The innate immune response to Leishmania formed within
the first hours after parasite inoculation is a determining
factor for the outcome of leishmaniasis [1]. We previously
revealed that the dsRNA genome of an endosymbiotic virus
within virulent Leishmania species is able to act as a potent
innate immunogen that worsens the outcome of cutaneous disease [5]. Although we showed the essential role of
TLR3, we could not formally exclude the role of other PRRs
in leishmaniasis such as the RIG-like receptors (RLRs) and
various members of the NOD-like receptors (NLRs).
In this study, we found that macrophage infection with
LgyLRV1+ parasites resulted in the transcriptional upregulation of several inflammasome components such as
caspase-1, IL-1β, NLRP3, and AIM2. These results mirrored
OPEN ACCESS | www.microbialcell.com
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those of a preliminary effort to profile the transcription of
inflammasome components in a macrophage system of
infection [25]. However, we found that L. guyanensis infection did not activate the inflammasome, irrespective of its
LRV1 status. Notably, an infection in primed macrophages
was unable to activate caspase-1 or IL-1β and mice deficient in the key inflammasome components ASC and
caspase-1/11 showed no change in their disease phenotype. Further, we found no role for RLR-signalling in response to LRV1, as removing its key signalling adaptor protein MAVS had no effect on cytokine production or parasite burden in vitro, nor did this defect have any impact on
disease progression in vivo. As MAVS is also a central or
synergising adaptor protein for other non-RLR pathways,
the unchanged phenotype in MAVS-/- mice also excluded
the RLR-independent pathway of virus-induced apoptosis
via MAVS-MKK7-JNK2 [47]. The absence of a role for RLR
signalling indicated that LRV1 was likely not able to exit the
phagolysosome to engage these receptors in the cytoplasm
and that LRV1 dsRNA recognition was limited to endosomal
TLR3.
NLRs are able to detect both PAMPs and DAMPs, which
are present in the destructive inflammatory environment
of a typical leishmaniasis lesion. NLRs have so far proven
protective in murine leishmaniasis caused by L. amazonensis, L. braziliensis and L. infantum. This protection was elicited by an NLRP3-dependent production of nitric oxide
(NO) involving IL-1β [24]. Upon incubation with LPS, the
resultant active IL-1β induced by NLRP3 signalling carried
out this response in an autocrine manner, whereby the IL-1
receptor and its MyD88 adaptor protein were necessary
and sufficient to trigger parasitotoxic oxidative stress via
inducible nitric oxide synthase (iNOS). It should also be
noted, however, that LPS can elicit a non-canonical activation of the inflammasome in the cytosol via caspase 11 and
its CARD domain [48]. It is likely that production of IL-1β is
not sufficient to control the disease for every Leishmania
species, since L. major was shown to induce IL-1β in
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FIGURE 6: LRV1 induces the expression of inflammasome-independent NLRs: NLRC2 and NLRC5. (A-B) BMDMs from C57BL/6 mice were
infected with LgyLRV1+ or LgyLRV1- parasites or stimulated with a synthetic TLR3 ligand, poly(I:C). After 6 hours, mRNA was quantified by
qRT-PCR for NLRC1 and NLRC2 (A) or for NLRC5, NLRX1 and NLRC3 (B). The bar graphs are representative of at least 3 independent experiments, using 2 technical and 2 biological replicates, and showed as mean ± SEM. Non-parametric Student’s t-test was performed. *p < 0.05,
**p < 0.01, ***p < 0.001. A cut off value of 2-fold was shown as a dotted line.

BMDMs when exposed to LPS, but lesion sizes were not
increased in caspase-1 deficient mice [24]. Another group
showed that blockade of IL-1β signalling rendered BALB/c
mice resistant to the infection [27]. Oppositely, NLRP3 inflammasome activation was required to establish nonhealing infection with a particular strain of L. major [26].
Our data showed that, even in the presence of LPS, Lgy
parasites did not activate the inflammasome. Therefore,
the question of species-specific inflammasome activation
and evasion remains to be determined. Of note, Leishmania parasites can be abundantly coated with the leucinerich-repeat (LRR)-enriched surface antigen PSA-2. Interestingly these antigens vary across Leishmania species, and
have been associated to increased virulence [49], which
could explain the discrepancies in inflammasome activation between different Leishmania species and/or strains.
Aside from parasite species, we cannot yet exclude that
other factors such as the site of infection (footpad or ear)
and the dose of parasites injected, which differ remarkably
between reports, could participate in inflammasome activation.
Inflammasome evasion could be an essential virulence
strategy in cutaneous leishmaniasis. This evasion could
occur via the catalytic activity of GP63, a ubiquitous metalloprotease on the surface of the Leishmania parasite,
which can cleave NLRP3 and inflammasome components
as shown in vitro but no evidence on the impact of GP63
has been provided to date in vivo [50]. Alternatively, the
deubiquitinating enzyme A20, which is a negative regulator
of NF-κB and TLR signalling in L. donovani infection [32]
was attributed a new role in suppressing inflammasome
activity [31, 33, 51]. We found that, similarly to L. donovani,
L. guyanensis infection induced A20 expression in macrophages. Interestingly, at 4 hours post infection, A20 expression was higher in LgyLRV1+ infected macrophages,
compared to LgyLRV1- or Poly (I:C) stimulation, suggesting
an additive role for TLR3 stimulation. It will be interesting
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to assess whether the same inhibition of inflammasome
activation by A20 is observed in models of Leishmania/virus co-infection where exogenous viral infection exacerbates the severity of L. guyanensis infection, promoting parasite dissemination and disease relapses, reproducing the phenotype of LgyLRV1+ infection [52].
The formation of an inflammasome is only one of the
many possible signalling pathways of NLRs. Many NLRs
respond to viral cues in inflammasome independent pathways. We found that LgyLRV1+ infection, or poly(I:C) treated macrophages, up-regulate the inflammasome independent NLRs: NLRC2 and NLRC5. Moreover, we showed
that the infection of mice deficient in NLRC2 but not NLRC5
led to a reduction in parasite burden and lesion size. These
results indicated that there could be an NLRC2–mediated
host dependent virulence mechanism other than the LRV1mediated inflammatory response. NLRC2 drives the recruitment of monocytes to the site of infection [42]. The
LRV1-mediated hyperinflammatory response that promotes parasite survival could require NLRC2-dependent
monocyte infiltration, cells which could in turn serve as
secondary host cells, thus explaining the reduction of disease severity in NLRC2-/- mice. This hypothesis will require
further investigation.
NLRC5 (CITA) is responsible for MHC-I transcription.
The role of MHC-I on CD8 cells in leishmaniasis shows a
distinct disease type-specificity as CD8+ T cells are detrimental to mucosal and metastatic infections [53], but protective in simple cutaneous leishmaniasis. The pathogenic
role of CD8+ T cells in L. braziliensis infection was shown to
be due to tissue-destructive levels of granzyme B [54]. It is
thus interesting that NLRC5 deficiency in mice had no effect on disease phenotype in L. guyanensis infection irrespective of LRV1 content, indicating that CD8+ T cells possibly do not play an important role in LRV1-mediated pathology.
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FIGURE 7: NLRC2 reduces LRV-mediated pathogenesis. (A-D) Mice were infected with LgyLRV1+ or LgyLRV1- parasites in their hind footpad. Weekly lesional swelling in infected NLRC2-/- (A) and NLRC5-/- (C) was monitored as a proxy for disease progression. At the peak of infection (4 weeks), parasite burden in infected NLRC2-/- (B) and NLRC5-/- (D) mice was measured by in vivo luminescence, by injecting mice intraperitoneally with 15mg/kg luciferin. The representative graph is shown from at least three independent experiments, using two biological
replicates in duplicates, and showed as mean ± SEM. Significance was calculated by Student’s t-test (bar graphs) or one-way Anova (disease
score), ns: non-significant.

Taken together, we were able to show that L. guyanensis evades inflammasome activation, where no central
components of the inflammasome impacted pathology in a
murine model of disease, irrespective of the presence of
LRV1. Additionally, we excluded the involvement of RLR
receptors in the development of Lgy pathology, and confirmed that LRV1 does not stimulate this cytoplasmic dsRNA receptor. Considering the potently protective role of
inflammasome activation previously found in infections by
other Leishmania species, these results indicated that inflammasome evasion might be an important mechanism of
virulence in Leishmania infection. Finally, as NLR and RLR
pathways are the major non-TLR3 routes of dsRNA-induced
inflammation, this work confirmed TLR3 as the major
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pathway of inflammatory pathology in LRV1-mediated cutaneous leishmaniasis.
MATERIALS AND METHODS
Ethical Statement
All animal protocols in this publication were approved by the
Swiss Federal Veterinary Office (SFVO), under the authorization numbers VD2113.1 and VD2113.2. Animal handling and
experimental procedures were undertaken with strict adherence to ethical guidelines set out by the SFVO and under inspection by the Department of Security and Environment of
the State of Vaud, Switzerland.
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In vitro parasite culture
Two isogenic clones of L. guyanensis (MHOM/BR/75/M4147)
showing uniformly high levels of LRV1 or completely lacking it
were described previously [55]. We refer to these clones as
LgyLRV1+ and LgyLRV1-, respectively. Both strains express a
firefly luciferase gene (LUC), integrated stably into the locus of
the small ribosomal subunit and displayed comparable luminescent efficacy [55]. In addition, two strains of L. infantum
were used. The first one was isolated from a dog in Spain (JPC
MCAN/ES/98/LLM-722) and will be referred as Linf S1, while
the second one was isolated from a human patient in Switzerland (MHOM/CH/2016/BELA) and will be referred as Linf S2.
Parasites were cultured in vitro as promastigotes at 26°C in
freshly prepared Schneider’s insect medium (Sigma) supplemented with 10% heat-inactivated fetal bovine serum (PAA®),
10mM HEPES and 50U/ml penicillin/streptomycin (Animed®),
0.6mg/L biopterin and 5mg/L hemin (Sigma-Aldrich®). Each
passage yielded infectious metacyclic promastigotes after 6
days and stocks were kept no longer than 5 passages.
Murine model of leishmaniasis
All mice were bred in a specific pathogen-free housing facility
at the University of Lausanne, Switzerland and backcrossed at
least 10 times onto a C57BL/6 genetic background (purchased
-/from Harlan Laboratories, Netherlands). Caspase-1/11 and
-/NLRC2
were purchased from Jackson Laboratories
(B6.129S2-Casp1tm1Flv/J and B6.129S1-Nod2tm1Flv/J respectively). The following genetic knock-outs were a kind gift from
-/-/-/Jürg Tschopp and previously described: MAVS , ASC , IL-1β ,
and NLRC5-/- [36, 56-58]. Age-matched (6-8 weeks old) female
6
mice were infected in the hind footpads with 3x10 stationary
phase LgyLRV1+ or LgyLRV1- promastigotes. Change in footpad swelling was measured weekly using a Vernier caliper as a
proxy for disease score.
Parasite quantification by luminescence
At the peak of infection (week 4/5) parasite burden was quantified using in vivo imaging able to detect luminescence emitted by luciferase-transfected parasites. Briefly, mice were
injected intra-peritoneally with D-Luciferin sodium salt (Regis
technologies®) prepared in PBS at a final concentration of
15 mg/kg. After a 10min incubation, mice were anesthetized
by continuous gas anesthesia and imaged using a Xenogen
Lumina II imaging system (IVIS®, 10min exposure time). Total
photon flux over the leishmanial lesions in the footpads was
assessed using the associated software (Living Image®).
BMDM culture, infection and stimulation
Bone marrow cells were extracted from naive C57BL/6 mice.
Erythrocytes were removed by lysis using ACK lysis buffer
(1,5M NH4Cl, 100mM KHCO3, 10mM EDTA-2Na) and then incubated with macrophage differentiation medium (complete
DMEM supplemented with L929-conditioned media) at 37°C.
After 6 days of differentiation, adherent BMDMs were isolated
6
and plated at 1x10 /ml in 48 well plates before being stimulated. Inflammasome activity assays used a pre-stimulation
step with 200 ng/ml LPS (Sigma-Aldrich®) for 3 hours. Cells
were then washed and infected (1:10) with stationary phase
LgyLRV1+ or LgyLRV1- parasites or stimulated with the synthetic TLR3 ligand, poly(I:C) (2 µg/ml, Sigma-Aldrich®) for 24
hours at 37°C. A positive control was treated with 5 µM nigericin (Sigma-Aldrich®) for 1 hour, while a negative control was
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left unstimulated after LPS pre-treatment. Alternatively, for
A20 measurement, BMDMs were infected (1:10) with stationary phase LgyLRV1+, LgyLRV1-, Linf S1 or Linf S2 parasites or
stimulated with poly(I:C) for 4 or 8 hours at 37°C.
Western blot
BMDMs were lysed with a mixture of RIPA Buffer IV (Biotech
RB4448), and a Protease/Phosphatase inhibitor cocktail (Cell
Signaling 5872S) in PBS. Laemmli’s Sample Buffer was added
before lysates were size-fractionated by SDS-PAGE and wettransferred to a nitrocellulose membrane. Western Blotting
was performed using the following antibodies: rabbit polyclonal anti-mouse caspase-1 p10 (Santa Cruz, SC514), goat polyclonal anti-mouse IL-1β (R&D Systems, AF-401-NA), rabbit
anti-mouse A20 (Cell Signaling, D13H3), mouse monoclonal
anti-mouse γ-tubulin (Sigma-Aldrich® T6557), goat anti-rabbit
IgG HRP conjugated (Promega W4011) and goat anti-mouse
IgG HRP conjugated (Promega W4021). Where indicated, protein expression was quantified with densitometric analysis
using ImageJ software.
High Content Microscopy
BMDMs were counted with Vi-Cell® (Beckman Coulter). Then,
6
0.1x10 BMMs were seeded on Falcon® 96 Well clear-bottom
Tissue-Culture treated plate. Cells were infected with stationary phase LgyLRV1+ or LgyLRV1- parasites (1:10) for 24 hours
and then fixed with freshly made 3.7% PFA in PBS. Cells were
subsequently stained with DAPI to visualize the nuclei of parasites and macrophages and washed in PBS using a Biotek MultioFlo FX plate washer. 49 (7x7 square) images from each well
with x40 lens were acquired using ImageXpress Micro XLS and
analyzed using MetaExpress software.
Statistical analysis
Statistical significance was determined using an unpaired parametric t-test (for single-point analysis on bar-graphs) or a
one-way Anova (x/y disease curves) as calculated by
GraphPad® software (Prism™ v5a). Significance was recognized when p ≤ 0.05 and represented in three ranks namely *:
p ≤ 0.05, **: p ≤ 0.01 and ***: p ≤ 0.001.
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